Short Interest in Mirion Technologies, Inc. (NYSE:MIR) Increases By 31.3%

Mirion Technologies, Inc. (NYSE:MIR) saw a significant increase in short interest in the month of June. As of June 15th, there was short interest totalling 4,410,000 shares, an increase of 31.3% from the May 31st total of 3,360,000 shares. Based on an average trading volume of 1,020,000 shares, the days-to-cover ratio is presently 4.3 days. Currently, 2.1% of the shares of the company are sold short.

Mirion Technologies Price Performance

Shares of Mirion Technologies stock opened at $10.74 on Friday. The company has a current ratio of 2.19, a quick ratio of 1.57 and a debt-to-equity ratio of 0.45. The company’s 50-day moving average price is $10.55 and its two-hundred day moving average price is $10.32. Mirion Technologies has a 52 week low of $6.70 and a 52 week high of $11.49. The stock has a market cap of $2.44 billion, a PE ratio of -26.20 and a beta of 0.80.

Mirion Technologies (NYSE:MIR) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $0.05 earnings per share for the quarter. The firm had revenue of $192.60 million for the quarter. Mirion Technologies had a positive return on equity of 3.44% and a negative net margin of 9.87%.

Wall Street Analyst Weigh In

Separately, Citigroup boosted their price target on shares of Mirion Technologies from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Monday, April 8th.

Insider Activity

In related news, CEO Thomas D. Logan sold 7,500 shares of Mirion Technologies stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $10.86, for a total transaction of $81,450.00. Following the sale, the chief executive officer now directly owns 1,544,017 shares in the company, valued at $16,768,024.62. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CAO Christopher A. Moore sold 8,153 shares of Mirion Technologies stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $10.29, for a total transaction of $83,894.37. Following the sale, the chief accounting officer now directly owns 28,128 shares in the company, valued at $289,437.12. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Thomas D. Logan sold 7,500 shares of the business’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $10.86, for a total transaction of $81,450.00. Following the completion of the sale, the chief executive officer now owns 1,544,017 shares in the company, valued at $16,768,024.62. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,153 shares of company stock valued at $351,669. 2.20% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Mirion Technologies

Institutional investors have recently bought and sold shares of the stock. Central Pacific Bank Trust Division purchased a new position in Mirion Technologies in the 1st quarter worth about $85,000. Bayesian Capital Management LP purchased a new position in Mirion Technologies during the 1st quarter valued at about $226,000. Lazard Asset Management LLC grew its stake in Mirion Technologies by 19.8% during the 1st quarter. Lazard Asset Management LLC now owns 22,751 shares of the company’s stock valued at $258,000 after acquiring an additional 3,753 shares in the last quarter. Victory Capital Management Inc. grew its stake in Mirion Technologies by 22.5% during the 4th quarter. Victory Capital Management Inc. now owns 27,873 shares of the company’s stock valued at $286,000 after acquiring an additional 5,119 shares in the last quarter. Finally, Trexquant Investment LP purchased a new position in Mirion Technologies during the 4th quarter valued at about $361,000. Hedge funds and other institutional investors own 78.51% of the company’s stock.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.